mTOR Kinase: A Possible Pharmacological Target in the Management of Chronic Pain
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
mTOR Kinase: A Possible Pharmacological Target in the Management of Chronic Pain
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-13
Publisher
Hindawi Limited
Online
2015-01-02
DOI
10.1155/2015/394257
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Opioid receptor–triggered spinal mTORC1 activation contributes to morphine tolerance and hyperalgesia
- (2014) Ji-Tian Xu et al. JOURNAL OF CLINICAL INVESTIGATION
- mTOR pathway is involved in ADP-evoked astrocyte activation and ATP release in the spinal dorsal horn in a rat neuropathic pain model
- (2014) J. Cui et al. NEUROSCIENCE
- Neuropathic pain: mechanisms and their clinical implications
- (2014) S. P. Cohen et al. BMJ-British Medical Journal
- Dual phosphorylation of Sin1 at T86 and T398 negatively regulates mTORC2 complex integrity and activity
- (2014) Pengda Liu et al. Protein & Cell
- The use of metformin is associated with decreased lumbar radiculopathy pain [Erratum]
- (2014) Theodore Price et al. Journal of Pain Research
- mTOR: A Link from the Extracellular Milieu to Transcriptional Regulation of Oligodendrocyte Development
- (2013) Teresa L. Wood et al. ASN Neuro
- Akt/mTOR signalling in myelination
- (2013) Camilla Norrmén et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Use of core modification in the discovery of CC214-2, an orally available, selective inhibitor of mTOR kinase
- (2013) Deborah S. Mortensen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: The discovery of AZD8055 and AZD2014
- (2013) Kurt G. Pike et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- mTOR and its downstream pathway are activated in the dorsal root ganglion and spinal cord after peripheral inflammation, but not after nerve injury
- (2013) Lingli Liang et al. BRAIN RESEARCH
- Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin
- (2013) Dareen M. Abdelaziz et al. BREAST CANCER RESEARCH AND TREATMENT
- Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR
- (2013) Q. Liu et al. CANCER RESEARCH
- Pain hypersensitivity mechanisms at a glance
- (2013) V. Gangadharan et al. Disease Models & Mechanisms
- The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma
- (2013) F Stenner-Liewen et al. Expert Review of Anticancer Therapy
- mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK
- (2013) Ohannes K. Melemedjian et al. PAIN
- Schwann cell autophagy counteracts the onset and chronification of neuropathic pain
- (2013) Sara Marinelli et al. PAIN
- Activation of mTOR in the spinal cord is required for pain hypersensitivity induced by chronic constriction injury in mice
- (2013) Wei Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The use of metformin is associated with decreased lumbar radiculopathy pain
- (2013) Theodore Guruguri et al. Journal of Pain Research
- Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors
- (2012) B. Markman et al. ANNALS OF ONCOLOGY
- Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR
- (2012) Si-meng Chen et al. BIOCHEMICAL PHARMACOLOGY
- Intercellular communication in sensory ganglia by purinergic receptors and gap junctions: Implications for chronic pain
- (2012) Menachem Hanani BRAIN RESEARCH
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis
- (2012) Cinzia Dello Russo et al. GLIA
- Kinome-wide Selectivity Profiling of ATP-competitive Mammalian Target of Rapamycin (mTOR) Inhibitors and Characterization of Their Binding Kinetics
- (2012) Qingsong Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis
- (2012) L. Lisi et al. JOURNAL OF NEUROIMMUNOLOGY
- Arrest of Myelination and Reduced Axon Growth When Schwann Cells Lack mTOR
- (2012) D. L. Sherman et al. JOURNAL OF NEUROSCIENCE
- Spinal Cord NMDA Receptor-Mediated Activation of Mammalian Target of Rapamycin Is Required for the Development and Maintenance of Bone Cancer-Induced Pain Hypersensitivities in Rats
- (2012) Ming-Hung Shih et al. JOURNAL OF PAIN
- Translational Investigation and Treatment of Neuropathic Pain
- (2012) Bo Xu et al. Molecular Pain
- The translational landscape of mTOR signalling steers cancer initiation and metastasis
- (2012) Andrew C. Hsieh et al. NATURE
- Alleviating Suffering 101 — Pain Relief in the United States
- (2012) Philip A. Pizzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- How to Use mTOR Inhibitors? The Search Goes On
- (2011) K. Budde AMERICAN JOURNAL OF TRANSPLANTATION
- ATP-Competitive Inhibitors of mTOR: An Update
- (2011) S. Schenone et al. CURRENT MEDICINAL CHEMISTRY
- Axonal protein synthesis: a potential target for pain relief?
- (2011) Ilona Obara et al. CURRENT OPINION IN PHARMACOLOGY
- Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
- (2011) Seth A. Wander et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a Potent, Selective, and Orally Available Mammalian Target of Rapamycin (mTOR) Inhibitor for Treatment of Cancer
- (2011) Qingsong Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects
- (2011) Alice De Corato et al. JOURNAL OF NEUROIMMUNOLOGY
- Spinal Phosphinositide 3-Kinase-Akt-Mammalian Target of Rapamycin Signaling Cascades in Inflammation-Induced Hyperalgesia
- (2011) Q. Xu et al. JOURNAL OF NEUROSCIENCE
- Ridaforolimus (AP23573; MK-8669), a Potent mTOR Inhibitor, Has Broad Antitumor Activity and Can Be Optimally Administered Using Intermittent Dosing Regimens
- (2011) V. M. Rivera et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical Characterization of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2: Distinct from Rapamycin
- (2011) S. V. Bhagwat et al. MOLECULAR CANCER THERAPEUTICS
- Targeting Adenosine Monophosphate-Activated Protein Kinase (AMPK) in Preclinical Models Reveals a Potential Mechanism for the Treatment of Neuropathic Pain
- (2011) Ohannes K Melemedjian et al. Molecular Pain
- Rapamycin passes the torch: a new generation of mTOR inhibitors
- (2011) Don Benjamin et al. NATURE REVIEWS DRUG DISCOVERY
- Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
- (2011) Francis X. McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical presentation and management of mTOR inhibitor-associated stomatitis
- (2011) Marcio Augusto de Oliveira et al. ORAL ONCOLOGY
- Systemic inhibition of the mammalian target of rapamycin (mTOR) pathway reduces neuropathic pain in mice
- (2011) Ilona Obara et al. PAIN
- Everolimus
- (2011) Monique P. Curran PEDIATRIC DRUGS
- Expression and distribution of mTOR, p70S6K, 4E-BP1, and their phosphorylated counterparts in rat dorsal root ganglion and spinal cord dorsal horn
- (2010) Ji-Tain Xu et al. BRAIN RESEARCH
- When does acute pain become chronic?
- (2010) C Voscopoulos et al. BRITISH JOURNAL OF ANAESTHESIA
- Beyond Rapalog Therapy: Preclinical Pharmacology and Antitumor Activity of WYE-125132, an ATP-Competitive and Specific Inhibitor of mTORC1 and mTORC2
- (2010) K. Yu et al. CANCER RESEARCH
- Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids
- (2010) Yasemin Sancak et al. CELL
- Docking proteins
- (2010) Tilman Brummer et al. FEBS Journal
- Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound26(PKI-587), a Highly Efficacious Dual Inhibitor
- (2010) Aranapakam M. Venkatesan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rapamycin Activates Autophagy and Improves Myelination in Explant Cultures from Neuropathic Mice
- (2010) S. Rangaraju et al. JOURNAL OF NEUROSCIENCE
- Mammalian Target of Rapamycin Signaling in the Spinal Cord Is Required for Neuronal Plasticity and Behavioral Hypersensitivity Associated With Neuropathy in the Rat
- (2010) Curtis O. Asante et al. JOURNAL OF PAIN
- Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition
- (2010) Calvin K. Yip et al. MOLECULAR CELL
- Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
- (2010) Katrin Düvel et al. MOLECULAR CELL
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress
- (2010) Shomit Sengupta et al. MOLECULAR CELL
- Mammalian target of rapamycin in spinal cord neurons mediates hypersensitivity induced by peripheral inflammation
- (2010) E. Norsted Gregory et al. NEUROSCIENCE
- Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy
- (2010) C A Sparks et al. ONCOGENE
- Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin
- (2010) Steven D. Knight et al. ACS Medicinal Chemistry Letters
- Rapamycin inhibits mTORC1, but not completely
- (2009) Carson C. Thoreen et al. Autophagy
- Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)
- (2009) Juan M. García-Martínez et al. BIOCHEMICAL JOURNAL
- Effect of ZSTK474, a Novel Phosphatidylinositol 3-Kinase Inhibitor, on DNA-Dependent Protein Kinase
- (2009) Dexin Kong et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- The discovery and optimisation of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase
- (2009) Karine Malagu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
- (2009) C. M. Chresta et al. CANCER RESEARCH
- Biochemical, Cellular, and In vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin
- (2009) K. Yu et al. CANCER RESEARCH
- Reflex sympathetic dystrophy in patients with metastatic renal cell carcinoma treated with Everolimus
- (2009) Christophe Massard et al. INVESTIGATIONAL NEW DRUGS
- An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
- (2009) Carson C. Thoreen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Rapamycin-Sensitive Signaling Pathway Is Essential for the Full Expression of Persistent Pain States
- (2009) S. M. Geranton et al. JOURNAL OF NEUROSCIENCE
- Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity
- (2009) Alban Latremoliere et al. JOURNAL OF PAIN
- Proinflammatory-Activated Trigeminal Satellite Cells Promote Neuronal Sensitization: Relevance for Migraine Pathology
- (2009) Alessandro Capuano et al. Molecular Pain
- Formalin-Induced Behavioural Hypersensitivity and Neuronal Hyperexcitability are Mediated by Rapid Protein Synthesis at the Spinal Level
- (2009) Curtis O Asante et al. Molecular Pain
- mTOR signaling: At the crossroads of plasticity, memory and disease
- (2009) Charles A. Hoeffer et al. TRENDS IN NEUROSCIENCES
- Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
- (2009) Morris E Feldman et al. PLOS BIOLOGY
- The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
- (2008) Jingxiang Huang et al. BIOCHEMICAL JOURNAL
- mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)
- (2008) Juan M. García-Martínez et al. BIOCHEMICAL JOURNAL
- A Vascular Targeted Pan Phosphoinositide 3-Kinase Inhibitor Prodrug, SF1126, with Antitumor and Antiangiogenic Activity
- (2008) J. R. Garlich et al. CANCER RESEARCH
- A New Pharmacologic Action of CCI-779 Involves FKBP12-Independent Inhibition of mTOR Kinase Activity and Profound Repression of Global Protein Synthesis
- (2008) B. Shor et al. CANCER RESEARCH
- The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2
- (2008) J. Huang et al. MOLECULAR AND CELLULAR BIOLOGY
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
- (2008) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- Regulation of TORC1 by Rag GTPases in nutrient response
- (2008) Eunjung Kim et al. NATURE CELL BIOLOGY
- Local Translation in Primary Afferent Fibers Regulates Nociception
- (2008) Lydia Jiménez-Díaz et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started